The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy (Q39811302)

14 September 2017

title

The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy (English)

1 reference

14 September 2017

1 reference

13

Yataro Daigo

1 reference

14 September 2017

Kazunori Yokomine

1

1 reference

14 September 2017

Satoru Senju

2

1 reference

14 September 2017

Tetsuya Nakatsura

3

1 reference

14 September 2017

Atsushi Irie

4

1 reference

14 September 2017

Yuki Hayashida

5

1 reference

14 September 2017

Yoshiaki Ikuta

6

1 reference

14 September 2017

Michiko Harao

7

1 reference

14 September 2017

Katsunori Imai

8

1 reference

14 September 2017

Hideo Baba

9

1 reference

14 September 2017

Hirotaka Iwase

10

1 reference

14 September 2017

Hiroaki Nomori

11

1 reference

14 September 2017

Koji Takahashi

12

1 reference

14 September 2017

Takuya Tsunoda

14

1 reference

14 September 2017

Yusuke Nakamura

15

1 reference

14 September 2017

Yutaka Sasaki

16

1 reference

14 September 2017

Yasuharu Nishimura

17

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

International Journal of Cancer

14 September 2017

published in

1 reference

14 September 2017

volume

126

1 reference

14 September 2017

issue

9

1 reference

14 September 2017

page(s)

2153-2163

1 reference

Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction

14 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.24836

Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FIJC.24836

Identification of tumour-associated T-cell epitopes for vaccine development

21 January 2018

1 reference

12 December 2020

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

1 reference

12 December 2020

Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection

1 reference

12 December 2020

Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis.

1 reference

12 December 2020

The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer

1 reference

12 December 2020

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

12 December 2020

Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1.

1 reference

12 December 2020

1 reference

12 December 2020

Global cancer statistics in the year 2000.

1 reference

12 December 2020

Ring finger protein 43 as a new target for cancer immunotherapy

1 reference

12 December 2020

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

1 reference

12 December 2020

Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy

1 reference

12 December 2020

Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas

1 reference

12 December 2020

A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment

1 reference

12 December 2020

Cancer immunotherapy: moving beyond current vaccines

1 reference

12 December 2020

Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes.

1 reference

12 December 2020

Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses

1 reference

12 December 2020

Regulators of apoptosis: suitable targets for immune therapy of cancer

1 reference

12 December 2020

Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe

1 reference

12 December 2020

Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas

1 reference

12 December 2020

FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells

1 reference

12 December 2020

FoxM1 is required for execution of the mitotic programme and chromosome stability

1 reference

12 December 2020

The winged-helix transcription factor Trident is expressed in cycling cells

1 reference

12 December 2020

HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL.

1 reference

12 December 2020

Gene cloning of immunogenic antigens overexpressed in pancreatic cancer

1 reference

12 December 2020

Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers

1 reference

12 December 2020

Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide

1 reference

12 December 2020

Development of a self-inactivating lentivirus vector.

1 reference

12 December 2020

Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity

1 reference

12 December 2020

A listing of human tumor antigens recognized by T cells

1 reference

12 December 2020

Protein kinase D2 contributes to either IL-2 promoter regulation or induction of cell death upon TCR stimulation depending on its activity in Jurkat cells

1 reference

12 December 2020

Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma

1 reference

12 December 2020

Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma

1 reference

12 December 2020

Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays

1 reference

12 December 2020

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma

1 reference

12 December 2020

Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.

1 reference

12 December 2020

The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer

1 reference

12 December 2020

Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice

1 reference

12 December 2020

Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

1 reference

12 December 2020

Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c

1 reference

12 December 2020

FOXM1 is a downstream target of Gli1 in basal cell carcinomas

1 reference

12 December 2020

Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice

1 reference

12 December 2020

H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies

1 reference

12 December 2020

Identification of glypican-3 as a novel tumor marker for melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.24836

1 reference

release_wwn7txyva5arvieiu3zf6p2qd4

14 September 2017

Fatcat ID

0 references

1 reference